Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2022-11-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a controlling shareholder, including detailed tables of shareholding and pledge status. It does not contain financial statements, management discussion, or audit information. It is a regulatory disclosure about share pledge status, which fits the category of a Regulatory Filing (RNS) as it is a compliance announcement about share pledges and related risks, not a financial report or capital change announcement.
2022-11-25 Chinese
2022年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "天津瑞普生物技术股份有限公司2022 年第三季度报告" which translates to "Tianjin Ruipu Biotechnology Co., Ltd. 2022 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and explanations of financial metrics for the third quarter of 2022. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period. It is not an announcement or a brief summary but a full financial report for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2022
2022-10-25 Chinese
第五届董事会第二次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the company's fifth board of directors' second (extraordinary) meeting. It includes details about the meeting date, attendance, and voting results on specific agenda items such as approval of the 2022 third quarter report and approval of additional related party transactions. The document does not contain the full quarterly report itself but references where the report can be found. It also includes procedural details and independent directors' opinions. This fits the category of Board/Management Information (MANG) as it announces board meeting decisions and management-related resolutions rather than providing the full financial report or detailed financial data.
2022-10-25 Chinese
第五届监事会第二次（临时）会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Tianjin Ruipu Biotechnology Co., Ltd. It details the meeting held on October 24, 2022, including approval of the 2022 third quarter report and approval of related party transactions. The document does not contain the actual financial report but rather the Supervisory Board's approval and confirmation of the report's compliance and accuracy. It also references where the full report can be found online. The document is short (963 characters) and serves as an official announcement of the Supervisory Board's meeting resolutions rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-10-25 Chinese
2022年第三季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (319 characters) indicating that the company's 2022 third quarter report has been published and is available on the stock exchange and information websites. It does not contain the actual financial data or the report itself, but rather directs investors to where the report can be found. According to the 'MENU VS MEAL' rule, such a brief notice about the report's availability is classified as a Report Publication Announcement (RPA).
2022-10-25 Chinese
关于新增2022年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected daily related party transactions for the year 2022. It includes details about the nature of the transactions, the related parties involved, approvals by the board and independent directors, and compliance with relevant stock exchange rules. The document is a formal disclosure of anticipated related party transactions rather than a financial report or audit. It does not contain financial statements or detailed financial analysis but focuses on governance and compliance aspects related to related party transactions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2022-10-25 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.